Taken together, these findings show that the Orai1/Orai3 ratio is higher in prostate cancer cells than in healthy tissue, which is consistent with the observation that Orai1 is elevated in early clinically localized cancer stage [68]. The gene discussed is ORAI3; the disease is prostate carcinoma.